How many institutions held BLRX - BioLineRx Ltd. - Ordinary shares, par value NIS 0.10 per share in Q1 2022?

24 institutional investors reported BLRX - BioLineRx Ltd. - Ordinary shares, par value NIS 0.10 per share for Q1 2022. Use the holders table for investor-level position and value details.

BioLineRx Ltd. - Ordinary shares, par value NIS 0.10 per share (BLRX)

Q: What does CUSIP 09071M205 represent in this 13F holders report?

CUSIP 09071M205 is the security identifier for BLRX - BioLineRx Ltd. - Ordinary shares, par value NIS 0.10 per share used to aggregate holder disclosures.

CUSIP: 09071M205

Q1 2022 13F Holders as of 31 Mar 2022

Security type / class: Equity / Ordinary shares, par value NIS 0.10 per share
Total 13F shares: 1,160,391
Total 13F value: $1,981,000
Share change: -1,274,430
Put/Call ratio: 147%
SEC-reported price per share: $1.71
Number of holders: 24
Value change: -$2,555,536
Number of buys: 8
Number of sells: 12
Shares outstanding: 2,048,819,940

Security key

09071M205

Report period

Q1 2022

Institutions

Top holders

BLRX full security history Ownership snapshot Full 13F holder table BioLineRx Ltd. SEC filings BioLineRx Ltd. company facts

Broader feeds

Latest 13F filings Latest 13D/G filings Investors directory

Ownership snapshot

Top reported holders of BLRX - BioLineRx Ltd. - Ordinary shares, par value NIS 0.10 per share (13F + 13D/G + 3/4/5)

Grouped by holder across the latest SEC ownership disclosures. Start with comparable ownership when available, then verify the linked 13F, 13D/G, or 3/4/5 evidence.

Comparable stake leader

ARK Investment Management...

Disclosed value leader

ARK Investment Management...

Comparable rows

15/15

Latest evidence

31 Dec 2021

13F Lead comparable stake: 0.05% Showing 1-6 of 15 holder rows.

Quick read

ARK Investment Management LLC leads the comparable SEC ownership view at 0.05%.

15 of 15 rows have a safely comparable ownership percentage. Use this as a filing-backed starting point, then open the detailed table for source links, reporting role, position value, share count, and filing date.

Open SEC evidence Opens ARK Investment Management LLC's linked filing trail.

Comparable ownership Top 5

ARK Investment Management LLC 0.05%

Parkman Healthcare Partners LLC 0.02%

MORGAN STANLEY 0.01%

PVG ASSET MANAGEMENT CORP 0.01%

ENVESTNET ASSET MANAGEMENT INC 0.01%

Ownership % is shown only when SEC disclosures are safely comparable across share classes.

Detailed SEC evidence table Showing 1-6 of 15 holder rows

Holder	Evidence	Ownership %	Position	12M Net Δ	As of
ARK Investment Management LLC	13F Company 13F	0.05%	$2,162,000 1,059,722 shares	—	31 Dec 2021
Parkman Healthcare Partners LLC	13F Company 13F	0.02%	$874,000 428,607 shares	—	31 Dec 2021
MORGAN STANLEY	13F Company 13F	0.01%	$531,000 260,166 shares	—	31 Dec 2021
PVG ASSET MANAGEMENT CORP	13F Company 13F	0.01%	$327,134 160,360 shares	—	31 Dec 2021
ENVESTNET ASSET MANAGEMENT INC	13F Company 13F	0.01%	$249,000 122,224 shares	—	31 Dec 2021
LPL Financial LLC	13F Company 13F	0%	$150,000 73,576 shares	—	31 Dec 2021

How to read this table

Rows are grouped by holder and ranked first by SEC-reported ownership % when it is safely comparable, then by disclosed holdings value. — indicates unavailable or non-comparable values; "mixed-class rows" means the latest filing spans non-comparable classes.

13F holder rows

Institutional holders as of Q1 2022

Investor-level positions for this CUSIP, loaded as an interactive table.

Institutions

1,160,391

Rows available

Investor	Option	Weight %	Change %	SEC-reported value	* Price	Shares	Share Change	Activity	Report Period

^* SEC-reported price is the security price as of the portfolio date and can indicate the last known price at which the security was still held. The marker flags a reported price that did not pass the local price check.

Compare Q1 2022 vs Q1 2022 Across Filers

Q1 2022 holders

Holder diff

Investor	Q1 2022 Shares	Q1 2022 Shares	Share Diff	Share Chg %	Q1 2022 value	Q1 2022 value	Value change	Value Chg %